Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06831357

Development and Validation of a Deep Learning Model to Predict Distant Metastases in Nasopharyngeal Carcinoma Using Whole Slide Imaging and MRI

Development and Multicenter Validation of a Deep Learning Model Based on Whole Slide Imaging and Magnetic Resonance Imaging of the Nasopharynx and Lymph Nodes to Predict Distant Metastases at Diagnosis in Nasopharyngeal Carcinoma

Status
Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

An AI model was developed to predict the likelihood of distant metastasis in patients with nasopharyngeal cancer based on pathology slides and MRI scans of the primary tumor. The model was validated using data from multiple centers. It was then applied to patients with advanced stages who were recommended to undergo PET/CT scans based on the NCCN or CSCO guidelines. This AI model can accurately screen patients with high risk of distant metastasis at the time of initial diagnosis to receive PET/CT, avoid excessive examination of patients with low risk of distant metastasis, save medical resources and reduce the economic burden on patients.

Detailed description

An AI model was constructed based on HE-stained pathological sections of the primary lesion and MRI of the nasopharynx and neck to predict the probability of distant metastasis at the first visit, and the AI model was fully verified by multicenter data; the AI model was applied to T3-4 or N2-3 patients who were recommended to undergo PET/CT examination according to the NCCN and CSCO guidelines, and the threshold of the AI model when the negative predictive value for predicting M0 was not less than 95% was determined, providing theoretical support for patients predicted by AI to be exempted from PET/CT examination.

Conditions

Timeline

Start date
2025-02-15
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2025-02-18
Last updated
2025-02-25

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT06831357. Inclusion in this directory is not an endorsement.